fbpx
September 22, 2020

EMA Panel Backs Baricitinib for Moderate-to-Severe Atopic Dermatitis EMA Panel Backs Baricitinib for Moderate-to-Severe Atopic Dermatitis

The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of baricitinib tablets (Olumiant, Eli Lilly) for adults with moderate-to-severe […]
September 19, 2020

Ruth Bader Ginsburg Dies From Pancreatic Cancer Ruth Bader Ginsburg Dies From Pancreatic Cancer

Justice Ruth Bader Ginsburg, a trailblazing jurist and the second woman appointed to the U.S. Supreme Court, died Friday. She was 87. The cause of death […]
September 18, 2020

EMA Backs Dexamethasone for Severe COVID-19 After Data Review EMA Backs Dexamethasone for Severe COVID-19 After Data Review

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The European Medicines Agency (EMA) has endorsed the use of dexamethasone in […]
September 15, 2020

Whistleblower: Forced Hysterectomies, COVID Spread at ICE Facility Whistleblower: Forced Hysterectomies, COVID Spread at ICE Facility

A private prison company is accused in a whistleblower complaint of failing to protect detainees and employees at a Georgia Immigration and Customs Enforcement (ICE) detention […]
September 10, 2020

FDA Clears New Neurosurgical Port for Deep Brain Access FDA Clears New Neurosurgical Port for Deep Brain Access

The US Food and Drug Administration (FDA) has granted marketing clearance to the MindsEye Expandable Port (Minnetronix Medical) for deep brain access during neurosurgical procedures, the […]
September 8, 2020

Pralsetinib: Second Drug for RET+ NSCLC Approved in US Pralsetinib: Second Drug for RET+ NSCLC Approved in US

A second drug is now available in the United States for use in the treatment of patients with metastatic non–small cell lung cancer (NSCLC) that tests […]
September 4, 2020

EMA Panel Backs Revoking Authorization of Ulipristal for Fibroids EMA Panel Backs Revoking Authorization of Ulipristal for Fibroids

The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has recommended revoking marketing authorization of ulipristal acetate (Esmya, Gedeon Richter, and generic medicines) for uterine […]
September 3, 2020

Problems With Implanted Spinal Cord Stimulators Prompt FDA Action Problems With Implanted Spinal Cord Stimulators Prompt FDA Action

Between July 27, 2016, and July 27, 2020, the US Food and Drug Administration (FDA) received a total of 107,728 medical device reports (MDRs) related to […]
September 3, 2020

FDA OKs Somapacitan (Sogroya), First Once-Weekly Growth Hormone FDA OKs Somapacitan (Sogroya), First Once-Weekly Growth Hormone

The US Food and Drug Administration (FDA) has approved somapacitan (Sogroya, Novo Nordisk) for the replacement of endogenous growth hormone in adults with growth hormone deficiency […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0